A detailed history of Davenport & CO LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Davenport & CO LLC holds 367,677 shares of TEVA stock, worth $6.78 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
367,677
Previous 372,658 1.34%
Holding current value
$6.78 Million
Previous $6.06 Million 9.41%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$15.81 - $18.96 $78,749 - $94,439
-4,981 Reduced 1.34%
367,677 $6.63 Million
Q2 2024

Aug 06, 2024

BUY
$12.78 - $17.4 $396,064 - $539,243
30,991 Added 9.07%
372,658 $6.06 Million
Q1 2024

May 03, 2024

BUY
$10.67 - $14.43 $3.65 Million - $4.93 Million
341,667 New
341,667 $4.82 Million
Q3 2022

Oct 11, 2022

BUY
$6.86 - $11.95 $98,838 - $172,175
14,408 New
14,408 $116,000
Q4 2021

Feb 10, 2022

SELL
$7.9 - $10.19 $94,578 - $121,994
-11,972 Closed
0 $0
Q3 2021

Oct 14, 2021

SELL
$8.38 - $10.18 $6,033 - $7,329
-720 Reduced 5.67%
11,972 $117,000
Q1 2021

Apr 28, 2021

BUY
$10.34 - $12.81 $22,799 - $28,246
2,205 Added 21.03%
12,692 $146,000
Q4 2020

Jan 13, 2021

SELL
$8.61 - $11.04 $23,247 - $29,807
-2,700 Reduced 20.47%
10,487 $101,000
Q3 2020

Oct 15, 2020

SELL
$8.57 - $12.69 $16,283 - $24,111
-1,900 Reduced 12.59%
13,187 $119,000
Q2 2020

Jul 28, 2020

BUY
$8.12 - $13.12 $25,066 - $40,501
3,087 Added 25.73%
15,087 $186,000
Q1 2020

May 05, 2020

SELL
$6.69 - $13.45 $3,345 - $6,725
-500 Reduced 4.0%
12,000 $108,000
Q4 2019

Jan 22, 2020

BUY
$6.53 - $10.72 $81,625 - $134,000
12,500 New
12,500 $123,000
Q4 2017

Jan 17, 2018

SELL
$11.23 - $19.1 $129,549 - $220,337
-11,536 Closed
0 $0
Q3 2017

Oct 12, 2017

BUY
$15.41 - $32.17 $177,769 - $371,113
11,536
11,536 $203 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Davenport & CO LLC Portfolio

Follow Davenport & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.